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Abstract
Laboratory models are often used to understand the interaction of related pathogens
via host immunity. For example, recent experiments where ferrets were exposed to two
influenza strains within a short period of time have shown how the effects of
cross-immunity vary with the time between exposures and the specific strains used.
On the other hand, studies of the workings of different arms of the immune response,
and their relative importance, typically use experiments involving a single infection.
However, inferring the relative importance of different immune components from this
type of data is challenging. Using simulations and mathematical modelling, here we
investigate whether the sequential infection experiment design can be used not only to
determine immune components contributing to cross-protection, but also to gain
insight into the immune response during a single infection.
We show that virological data from sequential infection experiments can be used to
accurately extract the timing and extent of cross-protection. Moreover, the broad
immune components responsible for such cross-protection can be determined. Such
data can also be used to infer the timing and strength of some immune components in
controlling a primary infection, even in the absence of serological data. By contrast,
single infection data cannot be used to reliably recover this information. Hence,
sequential infection data enhances our understanding of the mechanisms underlying
the control and resolution of infection, and generates new insight into how previous
exposure influences the time course of a subsequent infection.
Author summary
The resolution of an influenza infection requires different components of the immune
response to work together. Despite recent advances in mathematical modelling, we do
not well understand how much each broad immune component contributes to this
process at a given time. In this study, we show that laboratory data on the amount of
virus over the course of a single infection is insufficient for inferring the contribution of
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each broad immune component. However, if the animals are exposed to two different
virus strains with only days separating exposures, then the timing and strength of
protection provided by the first infection against the second provides crucial additional
information. We show how mathematical models can be used to recover the timing
and strength of each immune component, thus enhancing our understanding of how an
infection is controlled, and how a previous exposure changes the time course of a
subsequent infection.
Introduction
The influenza virus infects epithelial cells in the respiratory tract, causing respiratory
symptoms such as coughing and sneezing, and systemic symptoms such as fever.
Three main components of the immune response — innate, humoral adaptive and
cellular adaptive immunity — work together to control an infection. Experiments have
revealed the contribution of each major immune component to resolution of an
infection, by suppressing each immune component in turn [1–5]. However, current
mathematical models do not agree on how each major immune component contributes
quantitatively.
A study by Dobrovolny et al. [1] highlights these discrepancies. The study showed
that eight existing viral dynamics models [6–13] made different qualitative predictions
when different components of the immune response were removed. Each model failed
to reproduce the effect of removing at least one of the three components discussed
above. The discrepancies arose because many models were only fitted to viral load
data from a single infection.
It has been shown that many models can fit the viral load for a single infection
well, including models without a time-dependent immune response which are thought
to be less biologically realistic [6]; however, if data for multiple initial conditions are
available, the viral load may have more features to distinguish between competing
models [14, 15]. One way of altering the initial conditions is through a previous or
ongoing infection. We previously conducted a series of experiments where ferrets were
sequentially infected with two influenza strains [16, 17]. When a short time interval
(1–14 days) separated exposures, a primary infection protected against a subsequent
infection. This protection likely arose through cross-immunity, whereby the immune
response stimulated by one strain also protects against infection with another.
While immune markers indicated the approximate timing of each arm of the
immune response [18], the strength of cross-protection due to each component was
difficult to measure experimentally. We hypothesised that mathematical models can
be used to gain further insight from these types of experiments. Few existing models
include interactions between influenza strains on short timescales; hence, we
constructed viral dynamics models to reproduce the qualitative observations of these
experiments [19, 20]. The models also reproduce observations from a range of
experiments where immune components were suppressed [21].
Here, we use simulations to show that these mathematical models allow us to
extract the timing and strength of cross-protection from sequential infection data. By
attributing cross-protection to specific immune components, the models lead to new
insight into how previous exposure influences the time course of a subsequent infection.
Moreover, we find that compared to single infection experiments, sequential infection
experiments provide richer information on host immunity, and thus are potentially a
powerful tool to study immune-mediated control of a primary infection.
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Results
Synthetic data
As a first step to compare the information made available by sequential infection
versus single infection experiments, we generated synthetic datasets for each scenario.
Mimicking the experimental procedure of Laurie et al. [16], we generated a sequential
infection dataset where ferrets were exposed to two influenza strains, with intervals of
1, 3, 5, 7, 10 and 14 days between exposures; and a single infection dataset where
ferrets were exposed once only. Details are given in the Materials and Methods section.
Using synthetic data means that we know the ‘true’ contribution of each immune
component in resolving a single infection, and the ‘true’ extent of cross-protection
between infections.
Fig 1 shows a subset of the synthetic data. For a single infection, the viral load
trajectory can be split into exponential growth, plateau and decay phases. For short
inter-exposure intervals (1–5 days), infection with the challenge virus was delayed; for
long inter-exposure intervals (7–14 days), infection with the challenge virus was
unaffected. These features of the synthetic data match the qualitative results of Laurie
et al. [16] for infection with influenza A followed by influenza B, or vice versa. The
parameter values were chosen such that the delay was due to innate immunity. This
choice was made because experimentally, innate immune markers such as type I
interferon were observed to be elevated 1–5 days after a primary infection [18], and our
previous mathematical model incorporating the innate immune response made
predictions consistent with the observed temporary immunity [19]. The full set of
synthetic data is provided in S1 Fig.
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Fig 1. A subset of the synthetic data. (a) The line shows the simulated ‘true’ viral load for a single infection, with the
arrow showing the time of exposure. The simulated observed viral load is shown as crosses. The horizontal line indicates
the observation threshold (10 RNA copy no./100µL); observations below this threshold are plotted below this line. Values
below the observation threshold were treated as censored. (b–c) For sequential infections with the labelled inter-exposure
interval, the dashed and dotted lines show the simulated ‘true’ viral load for a primary and challenge infection respectively;
the arrows show the times of the primary and challenge exposures. The simulated observed viral load is shown as crosses.
Verification of the fitting procedure
In this section, we first verify that we could recover the simulated ‘true’ viral load by
fitting our model to the data. In the next section, we will sample from the joint
posterior distributions thus obtained to extract the contribution of each immune
component.
Fig 2a shows that the simulated ‘true’ viral load was recovered accurately when
fitting the model to either sequential infection or single infection data. The blue and
green (overlapping) areas are 95% credible intervals predicted by the models fitted to
the sequential infection and single infection data respectively. Both shaded areas
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included the simulated ‘true’ viral load, shown as the dotted line. This consistency
indicates that the fitting procedure accurately recovered the viral load.
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Fig 2. Verification that the fitting procedure recovered the viral load. (a) For a single infection, the blue and
green areas are the 95% credible intervals for the viral load (in the absence of noise), as predicted by the models fitted to the
sequential infection and single infection data respectively. (b–c) For sequential infections with the labelled inter-exposure
interval, the grey and blue areas show the 95% credible intervals for the primary and challenge viral load respectively,
predicted by the model fitted to sequential infection data. The other elements of the figure are identical to Fig 1: the
dashed and dotted lines show the simulated ‘true’ viral load for a primary and challenge infection respectively; the arrows
show the times of the primary and challenge exposures; and the horizontal line indicates the observation threshold.
Figs 2b–c confirm that fitting to sequential infection data accurately recovered the
viral load for different inter-exposure intervals. The grey and blue areas show the 95%
credible intervals for the primary and challenge viral load respectively.
Comparing the immunological information in each dataset
Next, we compared the behaviour of the fitted models to the behaviour of the ‘true’
parameters, to determine the information in each dataset on
• the effect of each immune component in controlling a single infection;
• cross-protection between strains; and
• each immune component’s contribution to cross-protection.
The effect of each immune component in controlling a single infection
In Fig 3, we removed adaptive immunity, both innate and adaptive immunity, humoral
adaptive immunity, or cellular adaptive immunity from the model. We then compared
predictions of the viral load for a single infection by the models fitted to the two
datasets.
First, we showed how the viral load trajectory for the ‘true’ parameters changed
when adaptive immunity was suppressed. We defined the ‘baseline’ as the viral load
when all immune components were present (red dotted lines in Fig 3, which are the
same as the black lines in Figs 1a and 2a). Suppressing adaptive immunity prevented
resolution of the infection (black dashed line in Fig 3a), which was consistent with
findings of a previous experiment [5]. The viral load deviated from the baseline
trajectory at 4 days post-exposure (vertical line), indicating that this was the time at
which adaptive immunity took effect.
We then asked whether the models fitted to the two datasets predicted this change.
Chronic infection in the absence of adaptive immunity was only predicted using
sequential infection data (Fig 3a). Single infection data did not enable consistent
prediction of this outcome, as indicated by the broadening prediction interval.
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Fig 3. Predicting the viral load for a single infection when various immune components were absent. The
vertical lines indicate, for the ‘true’ parameter values, the times at which the immune components labelled under each panel
took effect. These times were determined by when the viral load for the baseline model (red dotted line) deviated from the
viral load when the immune components were absent (black dashed line). These times were recovered using sequential
infection data in all of the panels (95% prediction intervals for the viral load in blue), while the timing of adaptive
immunity in (a) was recovered using single infection data (intervals in green). In addition, the viral load when adaptive
immunity was suppressed was accurately predicted using sequential infection data (a). However, the viral load was not
accurately predicted using either dataset in the remaining scenarios (b–d). Prediction intervals were constructed without
measurement noise.
However, both datasets enabled recovery of the time at which the viral loads in the
presence and absence of adaptive immunity deviated (the vertical line in Fig 3a).
Hence, the timing of adaptive immunity was accurately estimated using either dataset.
In Figs 3b–d, we repeated this procedure, suppressing (b) all immunity; (c)
humoral adaptive immunity; or (d) cellular adaptive immunity. When both innate and
adaptive immunity were suppressed, the peak viral load increased, and resolution of
the infection was delayed. These changes were consistent with a previous experiment
where innate immunity was suppressed [2].
Fig 3b shows that sequential infection data enabled accurate inference of when the
viral loads in the presence and absence of immunity deviated, hence recovering the
timing of innate immunity. By contrast, the model fitted to single infection data
predicted that the viral loads could deviate much earlier. Neither model accurately
predicted how the infection resolved in the absence of the immune response; however,
the prediction intervals for the model fitted to sequential infection data were tighter,
and the peak viral load was consistently predicted to be higher than for the baseline
model.
In the absence of the immune response, the infection resolves due to target cell
depletion only. The lack of predictive ability indicates that both datasets lack
information on how target cells would hypothetically become depleted, and how this
depletion would affect the viral load, in the absence of the immune response. One is
thus cautioned against using parameter values from a model fitted to data in
immunocompetent hosts to make predictions in situations where target cells may
become severely depleted, such as if individuals are immunocompromised.
Figs 3c–d show that neither dataset enabled prediction of how the viral load
changed when (c) the humoral adaptive immune response or (d) the cellular adaptive
immune response was removed. This implies that sequential infection data (of the
type reported in Laurie et al. [16]) cannot be used to distinguish the contributions of
antibodies and cellular adaptive immunity to resolution of infection. In detail, the
‘true’ parameters predicted that when humoral adaptive immunity was disabled, the
viral load rebounded instead of continuing to decrease (black dashed line in Fig 3c).
When cellular adaptive immunity was disabled, resolution of the infection was delayed
(black dashed line in Fig 3d). The fitted model’s predictions ranged from no delay to a
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chronic infection.
Cross-protection between strains
Given the above mixed results, we then tested whether sequential infection data
accurately captured the timing and extent of cross-protection, by simulating the viral
load for inter-exposure intervals other than those where data was provided. We
selected new inter-exposure intervals of 2 and 20 days; the former lay between
inter-exposure intervals included in the original data (1, 3, 5, 7, 10 and 14 days), while
the latter lay outside this range. Then, using the models fitted to the original data
(that is, not re-fitting to the new data), we predicted the challenge viral load for these
new inter-exposure intervals. Because a primary infection could greatly affect a
challenge infection, but not vice versa, we focused on the behaviour of the challenge
infection.
Fig 4 shows that predictions by the model fitted to sequential infection data (blue
areas) were accurate. By contrast, predictions using single infection data (green) did
not agree well with the ‘true’ viral load. Note that to predict cross-protection using
single infection data, we used the model assumptions that innate immunity was
completely non-specific and antibodies were completely strain-specific, and considered
the optimistic scenario where we had independent, perfect information about the
proportion of cellular adaptive immunity that was cross-reactive (details in the
Materials and Methods section). Even then, single infection data did not accurately
capture cross-protection.
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Fig 4. Predicting the outcomes of further sequential infection experiments. Sequential infection data, but not
single infection data, enabled prediction of further sequential infection experiment outcomes. The lines show the simulated
‘true’ viral loads for inter-exposure intervals of 2 and 20 days. The shaded areas show the 95% prediction intervals for the
challenge viral load.
Each immune component’s contribution to cross-protection
Having shown that the sequential infection data captures the timing and extent of
cross-protection between strains, we then asked whether such cross-protection could be
attributed to the ‘correct’ mechanisms (the same mechanisms as given by the ‘true’
parameters). These mechanisms are
• target cell depletion due to the infection and subsequent death of cells;
• innate immunity; and
• cellular adaptive immunity.
In our model, antibodies are strain-specific and thus do not contribute to
cross-protection.
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Before analysing the behaviour of the fitted models, we quantified how each
immune component contributed to cross-protection for the ‘true’ parameters. In Fig 5,
for a one-day inter-exposure interval, we plotted in red the challenge viral load for the
baseline model (the original model fitted to the data, where all three of the above
immune components can mediate cross-protection). We observed that the challenge
infection was delayed relative to a primary infection. We then modified the baseline
model such that only a subset of immune components mediates cross-protection, as
detailed in the Materials and Methods section. We used the modified model to predict
the viral load (in black), and compared it with the baseline viral load. (The blue areas
will be discussed shortly.)
For example, in Fig 5a, we modified the baseline model such that only cellular
adaptive immunity, and not target cell depletion or innate immunity, can mediate
cross-protection. We denoted this modified model ‘model XC’. Unlike the baseline
model (red dotted line), the challenge viral load for model XC was not delayed (black
solid line); in fact, it closely resembled that for a single infection. Comparing the two
simulations led to the conclusion that cellular adaptive immunity did not play a major
part in cross-protection.
We then modified the baseline model such that only target cell depletion and/or
innate immunity, but not cellular adaptive immunity, can mediate cross-protection.
We denoted this model ‘model XIT’. The challenge viral loads according to model XIT
and the baseline model were very similar (overlapping lines in Fig 5b). Hence, for the
‘true’ parameters, cross-protection was mediated by innate immunity and/or target
cell depletion.
To distinguish between these two mechanisms, we constructed model XI, where
only innate immunity, and not target cell depletion or cellular adaptive immunity, can
mediate cross-protection. Once again, the challenge viral load was very similar to the
baseline model. We concluded that the cross-protection was largely mediated by
innate immunity.
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Fig 5. Predictions of the challenge viral load for a one-day inter-exposure interval when the mechanisms
mediating cross-protection were restricted. The red dotted lines show the challenge viral load for the ‘true’
parameter values when the mechanisms mediating cross-protection were restricted. The black solid lines show the viral load
for the baseline model. Comparing the two sets of lines revealed that innate immunity mediated cross-protection, whereas
cellular adaptive immunity did little to mediate cross-protection. The model fitted to sequential infection data accurately
predicted the challenge outcomes for models XC and XIT, but not model XI (95% prediction intervals shown). It thus
correctly attributed cross-protection to target cell depletion and/or innate immunity, but could not definitively distinguish
between the two. The viral load for the primary infection is not shown, to improve clarity of the figure.
Having demonstrated the utility of the modified models, we returned to the
original question of whether sequential infection data could be used to distinguish
between mechanisms for cross-protection. We sampled parameter sets from the joint
posterior distributions obtained by fitting the baseline model to sequential infection
data, and used them as inputs for models XC, XIT and XI respectively, to generate
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the blue areas in Fig 5. If the fitted parameters and the ‘true’ parameters predict the
same infection outcomes under the modified models, then the fitted model attributes
cross-protection to the ‘correct’ mechanisms.
Models XC and XIT made the same predictions using the fitted parameters (shaded
area) and the ‘true’ parameters (black line), so sequential infection data enabled us to
accurately attribute cross-protection to target cell depletion and/or innate immunity,
rather than cellular adaptive immunity. On the other hand, the fitted parameters did
not consistently predict the challenge outcome for model XI (Fig 5b). Hence, we could
not use sequential infection data to consistently rule out the possibility that
cross-protection occurred due to target cell depletion rather than innate immunity.
However, only a very small proportion of trajectories sampled from the joint posterior
distribution incorrectly attributed the delay to target cell depletion (S2 Fig).
Similarly, we were unable to disentangle different mechanisms of innate immunity
from the sequential infection data alone (S3 Fig and S1 File).
For infection with heterologous influenza A strains, rather than the influenza A
and B strains discussed thus far, we hypothesise that innate and cellular adaptive
immunity contribute to cross-protection at different inter-exposure intervals [22].
S2 File presents the same analysis for this scenario, where we were able to unravel
these different contribution using sequential infection data.
In summary, the synthetic sequential infection data enabled accurate inference of
the contribution of cellular adaptive immunity to cross-protection, as well as the
combined contributions of target cell depletion and innate immunity. However, using
this data alone, we could not conclusively distinguish the contributions of innate
immunity and target cell depletion to cross-protection, or distinguish the contributions
of different innate immune mechanisms.
Discussion
Advantages of sequential infection experiments
In this study, we have simulated experiments which investigate the interaction of
influenza strains through sequential infections, then explored how mathematical
models could be applied to the data to gain insight into immune mechanisms. Our
analysis has shown that the sequential infection study design, compared to the single
infection study design, provides richer information for inferring the timing and
strength of each immune component.
We have identified three main advantages of sequential infection data. The first
advantage is in inferring how each immune component helps to resolve a single
infection. We found that the synthetic sequential infection data captures the timing of
innate and adaptive immunity during a single infection, and thus enables accurate
prediction of the outcomes of some in silico experiments where immune components
were removed. In contrast, we could not consistently infer the timing and strength of
innate immunity from single infection data. Moreover, this type of data contains
information only on the timing of adaptive immunity, but not the effects of
suppressing adaptive immunity.
The second advantage is that sequential infection data contains more information
on the effects of cross-protection. We were able to use the model fitted to the
sequential infection data to precisely predict outcomes of further such experiments
using the same strains but different inter-exposure intervals. Using the model fitted to
the single infection data greatly reduced predictive power.
The third advantage is in inferring the contribution of each immune component to
this cross-protection. The synthetic sequential infection data allowed us to infer the
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contribution of cellular adaptive immunity to cross-protection, as well as the combined
contributions of target cell depletion and innate immunity.
Collectively, the above findings strongly suggest that analysing real sequential
infection data using mathematical models will help infer the timing and strength of
host immunity, which are difficult to measure directly in laboratory experiments. Such
mathematical models will not only have the ability to explain observed experimental
outcomes, but the ability to predict outcomes of new experiments, which can then be
tested in the laboratory. These findings are particularly important as sequential
infection experiments are increasingly being used to study the role of the immune
response during infection with influenza and other respiratory pathogens [17, 23].
Repeating the entire study with different noisy datasets (with the same ‘true’
parameters) did not change these findings (data and analysis not shown).
Limitations of sequential infection experiments
This study has highlighted some limitations of quantifying the immune response using
virological data from sequential infection experiments alone.
Firstly, using the synthetic sequential infection data, we could not discriminate
between the effects of cellular and humoral adaptive immunity in controlling a primary
infection. If the effects of cellular and humoral adaptive immunity need to be
distinguished, such as to predict the effects of vaccines that boost these components
separately, quantities other than the viral load may need to be measured.
Secondly, we could not definitively rule out the possibility that target cell depletion
contributed significantly to cross-protection. We were also unable to distinguish the
roles of different innate immune mechanisms in cross-protection. Some modelling
applications may require the strengths of different innate immune mechanisms to be
known separately. An example of such an application is modelling the effect of
treatments that modulate the innate immune response, such as the toll-like receptor-2
agonist Pam2Cys which has been shown to stimulate innate immune signals and
reduce influenza-associated mortality and morbidity in animal studies [24].
In addition to total viral load data, the study by Laurie et al. [16] also included
infectious viral load measurements for single infection ferrets, and serological responses
and cytokine levels at limited time points. Inclusion of this data could help to address
the above limitations; the utility of this additional data can be assessed by further
simulation-based studies.
New experiments could also be conducted to improve parameter estimates, leading
to more accurate inference of the timing and strength of immune components.
Previous studies have measured viral decay rates in vitro and incorporated these
estimates into model fitting [25,26]. In vitro studies can also directly measure the time
course of those immune mechanisms which are active in vitro [27].
Future work and concluding summary
Now that we have shown how mathematical models can increase the utility of
sequential infection experiments, fitting the model to the experimental data by Laurie
et al. [16] is our priority. A simulation-estimation study alone cannot validate the
mathematical model used, or infer the effects of host immunity against the pathogens
in the experiments. However, this study ensures that results will be interpreted
appropriately when the models are fitted to data.
We have demonstrated that relative to single infection experiments, the sequential
infection study design helps us to better understand cross-protection on short
timescales. Further, data from sequential infection experiments helps to discriminate
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between existing models for a primary infection, leading to an improved understanding
of the control and resolution of an infection.
Materials and methods
The model
Viral dynamics
The viral dynamics model is based on a model we previously published [22]. It
incorporates three major components of the immune response — innate, humoral
adaptive and cellular adaptive.
Fig 6 shows a compartmental diagram of the model for a single strain. The system
is described by a coupled set of ordinary differential equations (Eqs 1–4).
F-
A+
F+
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Interferon 
(F)
Total virus 
(Vtot)
Infectious 
virus (Vinf)
F+
E+Target 
cells (T)
Infected 
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Naive B 
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(A)Vtot+
Naive T 
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cell (E)
Refractory 
T cell (M)
I+
Fig 6. The within-host influenza model for a single strain. (Top) Viral dynamics and innate immune response;
(middle) humoral adaptive immune response; (bottom) cellular adaptive immune response. Solid arrows indicate transitions
between compartments or death (shown only for immune-enhanced death processes); dashed arrows indicate production;
plus signs indicate an increased transition rate due to the indicated compartment.
dT
dt
= g(T +R)
(
1−
T +R+ I
T0
)
− βVinfT + ρR− φFT, (1a)
dI
dt
= βVinfT − (δI + κFF + κEE) I, (1b)
dVinf
dt
=
pV inf
1 + sF
I − (δV inf + κAA+ βT )Vinf , (1c)
dVtot
dt
=
pV infpV ratioα
1 + sF
I − δV totVtot − αβTVinf . (1d)
Eq 1 describes the dynamics of target cells (T ), infected cells (I) and virions (Vinf
and Vtot for infectious and total virions respectively). Virions (Vinf ) bind to target
cells (T ) to infect them; infected cells (I) produce virions; and infected cells and
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virions both decay at a constant rate. Target cells also regrow, with an imposed
carrying capacity. Immunity is mediated by the compartments R (resistant cells), F
(type I interferon), A (antibodies) and E (effector CD8+ T cells), the dynamics of
which will be described shortly. Descriptions of model parameters are given in
S1 Table–S4 Table, and in our previous publication [22].
The compartment Vinf refers to the number of infectious virions in the host;
however, an infected cell produces both infectious and non-infectious virions, the latter
of which arise due to defects introduced during the viral replication process [28, 29].
Moreover, in the experiments conducted by Laurie et al. [16], the total viral load,
rather than the number of infectious virions, was measured. An additional
complication is that the concentration of total nasal wash, rather than the absolute
number of virions, was measured. Hence, we include Eq 1d for the total virion
concentration Vtot.
Innate immunity is mediated through type I interferon (F ), the production of
which is stimulated by infected cells. Three effects of type I interferon are modelled
through Eqs 1–2:
• rendering target cells temporarily resistant to infection (T → R);
• decreasing the production rate of virions from infected cells; and
• increasing the decay rate of infected cells.
dR
dt
= φFT − ρR, (2a)
dF
dt
= I − δFF. (2b)
The humoral adaptive immune response is mediated by antibodies (A), which bind
to virions and neutralise them, rendering them non-infectious. Naive B cells (B0) are
stimulated by virus to proliferate and differentiate into plasma cells (P ), which
produce antibodies. Eq 3 describes these processes.
dB0
dt
= −
Vtot
kB + Vtot
βBB0, (3a)
dB1
dt
=
Vtot
kB + Vtot
βBB0 −
(
nB
τB
+ δB
)
B1, (3b)
dBi
dt
=
2nBBi−1
τB
−
(
nB
τB
+ δB
)
Bi, i = 2, ..., nB, (3c)
dP
dt
=
2nBBnB
τB
− δBP, (3d)
dA
dt
= P − δAA. (3e)
The cellular adaptive immune response is mediated by effector CD8+ T cells (E).
Infected cells stimulate the differentiation of effector CD8+ T cells from their naive
counterparts (C); effector CD8+ T cells then increase the death rate of infected cells.
Some effector CD8+ T cells remain after a primary infection as memory CD8+ T cells.
After a refractory period (represented by the M stage), they are modelled as having
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the same dynamics as naive cells, and can be re-stimulated to become effector CD8+ T
cells upon challenge. Eq 4 describes these processes.
dC
dt
=
M
τM
−
I/kC
1 + I/kC
βCC, (4a)
dE1
dt
=
I/kC
1 + I/kC
βCC −
(
nE
τE
+ δE
)
E1, (4b)
dEi
dt
=
2nEEi−1
τE
−
(
nE
τE
+ δE
)
Ei, i = 2, ..., nE − 1, (4c)
dEnE
dt
=
2nEEnE−1
τE
− δEEnE , (4d)
E =
nE∑
i=1
Ei, (4e)
dM
dt
= ǫδEEnE − δEM −
M
τM
. (4f)
When more than one strain co-infects the host, the strains interact in three ways:
• competition for target cells, which become depleted due to the infection and
subsequent death of cells;
• innate immunity, which acts across all strains; and
• cellular adaptive immunity, which can be partly cross-reactive.
Activation of each of these mechanisms by the primary virus lowers the effective
reproduction number of the challenge strain, but to different extents depending on
parameter values. Note that because the model includes target cell regrowth, infection
with the challenge virus can become established despite target cell depletion due to
the death of infected cells. Each naive CD8+ T cell pool can be stimulated by one or
more virus strains, depending on model parameters; cross-reactivity arises when a T
cell pool could be stimulated by more than one virus strain. The clearance of infected
cells by effector CD8+ T cells is similarly strain-specific. The antibody response is
modelled as completely strain-specific, with no cross-reactivity between strains. It is
thus unnecessary to include long-term humoral adaptive immunity. Extension of the
model to include the potential effects of antibody-mediated cross-protection (as
reviewed by [30]) is the subject of future work.
S4 Fig illustrates the model for two strains and three T cell pools; the equations
are given in S1 File. Three T cell pools is a parsimonious choice, to allow for one pool
to be cross-reactive between strains and two pools to be strain-specific, one for each
strain.
Observation model
Observations were simulated from the ‘true’ viral load by adding lognormal noise and
imposing a detection threshold. Mathematically, the measured viral load yqfk for each
virus q = 1, 2, . . . , Q, ferret f = 1, 2, . . . , F and measuring time point tqfk where
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k = 1, 2, . . . ,Kqf is given by
yqfk =
{
Vtotq(tqfk, uf ,β)10
eqfk when Vtotq(tqfk, uf ,β)10
eqfk ≥ Θ
0 otherwise
(5a)
where eqfk
i.i.d.
∼ N (0, σ). (5b)
β is a vector of parameter values, uf is the inter-exposure interval for ferret f , eqfk is
the measurement error, and Θ is the detection threshold. Vtotq(tqfk, uf ,β) is the
solution to the two-strain version of Eqs 1–4 for the Vtotq compartment at time tqfk
for the given parameter values and inter-exposure intervals. Θ takes the value 10 RNA
copies/100µL in the experiments by Laurie et al. [16]. A measured viral load of 0
denotes that the viral load is below the detection threshold.
Therefore the likelihood of the model given the data is
P (y|θ) =
Q∏
q=1
F∏
f=1
Kqf∏
k=1
P (yqfk|θ) where (6a)
P (yqfk|θ) =


1√
2σ2pi
exp
{
− [log10 yqfk−log10 Vtotq(tqfk ,uf ,β)]
2
2σ2
}
if yqfk ≥ Θ,∫
Θ
0
1√
2σ2pi
exp
{
−
[log
10
x−log
10
Vtotq(tqfk,uf ,β)]
2
2σ2
}
dx if yqfk = 0,
0 otherwise.
(6b)
In the second line of Eq 6b, the likelihood when the data is below the detection
threshold is obtained by integrating the probability density function from 0 to the
detection threshold, i.e. treating the data below the threshold as censored [31]. The
vector θ contains the parameters β, the inter-exposure intervals uf , the time points
tqfk, and the standard deviation σ of the measurement error.
Simulated experiments
The model and the chosen ‘true’ parameters were used to generate synthetic data akin
to that in Laurie et al. [16]. For six ferrets, intervals of 1, 3, 5, 7, 10 and 14 days
separated exposures to two influenza strains. In addition, thirteen ferrets were
exposed to a single influenza strain only. The sequential infection dataset consists of
the viral load for the six sequential infection ferrets and one single infection ferret; the
single infection dataset consists of the viral load for the thirteen single infection ferrets.
The number of single infection ferrets was chosen such that the number of exposures
to influenza virus is the same in each dataset, and so the number of data points is
roughly the same.
Selection of model parameters to generate synthetic data
The ‘true’ parameter values chosen to generate the synthetic data are given in
S1 Table–S4 Table. The parameters were assumed to be identical between the two
strains, except for the parameters governing cross-reactivity in the cellular adaptive
immune response. In addition to the criteria discussed in the Results section, the
parameters were chosen to reproduce qualitative behaviour for a single infection when
immune components are suppressed:
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• when the innate adaptive immune response is absent (F → 0), the peak viral
load increases [2];
• when the humoral adaptive immune response is absent (A→ 0), the viral load
rebounds [3];
• when the cellular adaptive immune response is absent (E → 0), resolution of the
infection is delayed [4]; and
• when both arms of the adaptive immune response are absent (A,E → 0), chronic
infection ensues [5].
For an extensive evaluation of a very similar model’s behaviour under these types of
conditions (for single infection events), see [21].
In addition to parameter values, initial values were required when simulating
infections. For a single infection, the initial values for all compartments in Eqs 1–4
except T , Vinf , Vtot, C and B0 were zero. The initial values of C and B0 (naive T and
B cells respectively) were normalised to 1. The initial values of T and Vinf (the
number of target cells and the concentration of infectious virions respectively) were
estimated parameters. The initial concentration of total virus was then
Vtot(0) = γαVinf (0), where γ and α were conversion parameters described in S1 Table.
For sequential infections, the conditions at the time of the primary exposure were as
above; the system was integrated until the time of the challenge exposure, at which
Vinf,2(0) infectious virions for the challenge strain was added to the system, and the
total concentration of the challenge strain was set to Vtot,2(0).
Model fitting
Parameters to be estimated
All model parameters were estimated, except for the following parameters which were
either fixed or a function of other estimated parameters. We fixed two parameters —
the number of plasmablast division cycles (nB) and the number of effector CD8
+ T
cell division cycles (nE) — to be 5 [32, 33] and 20 [34] respectively. In addition, when
fitting the model to single infection data, we considered the optimistic scenario where
we had independent, perfect information about the proportion of cellular adaptive
immunity during a primary infection that was cross-reactive with the challenge strain.
As one T cell pool was cross-reactive between strains and two pools were
strain-specific, this amounted to fixing the proportion of cellular adaptive immunity
attributed to each T cell pool. We did so by fixing the numbers of infected cells for
half-maximal stimulation of naive CD8+ T cells kCj1 to their ‘true’ values for each T
cell pool j. Then when we extended the model to two strains, we set kCjq to these
same ‘true’ values. We then calculated the scaled clearance rates of infected cells by
effector CD8+ T cells κEjq by taking the fitted value of κE11, and applying the
formula κEjq = κE11kC11/kCjq.
Instead of fitting the infectivity (β) and the production rate of infectious virions
from an infected cell (pV inf ), we fitted the basic reproduction number R0 (Eq 7) and
the initial viral load growth rate r (Eq 9), as we hypothesised that these were more
intimately linked to features of the viral load curve. Practically speaking, we proposed
a new value for R0 (or r), calculated the corresponding values of β and pV inf , solved
the model equations, calculated the likelihood of the data given the parameters, and
accepted or rejected the new value for R0 (or r).
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The basic reproduction number R0 is the mean number of secondary infected cells
due to (the virions produced by) a single infected cell. The expression for R0 is
R0 =
βT0pV inf
(δV inf + βT0)δI
, (7)
and is the same as that for a model without a time-dependent immune response [35].
The viral load during early infection can be approximated by
V = V0 exp(rt). (8)
Arenas et al. [36] showed using a simulation-estimation study that this parameter was
well estimated even when only viral load data was available.
The expression for r, derived by linearising Eq 1 around the disease-free
equilibrium [37], is
r = −
δV inf + βT0 + δI
2
+
√
(δI − δV inf − βT0)2 + 4βT0pV inf
2
. (9)
Prior distributions
We began with a uniform distribution in parameter space whose bounds along each
dimension are given in S1 Table–S4 Table. Note that parameter estimation was
performed in a parameter space where all parameters except for the standard
deviation of the measurement error σ were log transformed. Then, we excluded
regions of parameter space where the parameters log10 β and log10 pV inf , which were
not directly estimated but were instead recovered from Eqs 7 and 9, were outside the
bounds given in S1 Table.
The priors were deliberately chosen to be wide because previous parameter
estimates came from a range of experimental systems, and parameters with similar
physical definitions could vary in value depending on the model used. The bounds for
viral replication parameters were based on those by Petrie et al. [38] where the
equivalent parameters exist. Otherwise, where multiple estimates existed in the
literature (as cited in the tables), the bounds were chosen to encompass all of them.
Where we could only find a single estimate, bounds spanning at least an order of
magnitude were chosen (unless the parameter is a pure rate parameter, as discussed
shortly). Where no estimate was found, we assigned very wide bounds spanning much
more than one order of magnitude. In general, the bounds for pure rate parameters
(those with units day−1 only) were chosen to be narrower as their order of magnitude
was known, whereas bounds for parameters such as R0 were much wider.
Furthermore, for computational efficiency, some minimal constraints on the
behaviour of the viral load and timing of various immune components were
incorporated into the prior distribution. These constraints were imposed because
parameter sets that generate ‘unreasonable’ viral load trajectories for a single infection
caused large delays in numerical integration of the two-strain differential equations.
The inclusion criteria were that for a single infection,
• the total viral load rises by at least one order of magnitude during infection;
• the total viral load peaks 0–7 days post-exposure;
• the humoral adaptive immune response is not active too early (five days
post-exposure, the neutralisation rate of virus by antibodies, κAA, does not
exceed 103 day−1); and
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• the cellular adaptive immune response is not active too early (five days
post-exposure, the clearance rate of infected cells by effector CD8+ T cells,∑J
j=1 κEj1Ej , does not exceed 10
3 day−1).
If the viral load trajectory (in the absence of measurement noise) predicted by a
parameter set does not fulfil all of these conditions, the value of the prior distribution
is zero at that point in parameter space.
Model fitting algorithm
We fitted the model using the Metropolis algorithm [39,40] embedded within a Gibbs
sampler structure [41], implemented in Octave 3.8.2 [42]. To evaluate the likelihood,
Eqs 1–4 were solved using the CVODE solvers developed by [43], implemented in
MATLAB [44]. Of the available solvers, a backward differentiation formula method in
variable order, variable step, fixed leading coefficient form was chosen. Extinction was
enforced by defining an infection to have resolved if both the number of infected cells
and virions was below 0.1.
To assess convergence, three chains were run in parallel using different starting
parameter values θ0 drawn from the prior distribution. The procedure for determining
the number of iterations for which to run the chains is detailed in S1 Text. For
efficient mixing, the proposal distributions were tuned such that the proportion of
accepted proposals was not too low or too high, as detailed in S1 Text. For each of the
three chains, parallel tempering (as developed by [45] and reviewed by [46]) was
implemented to improve exploration of parameter space. The number of iterations
before testing whether to swap chains in the parallel tempering process was set to 10.
During the calibration period for the proposal distributions, the temperatures were
also calibrated [47], as detailed in S1 Text. Once convergence was reached, the
effective sample size was calculated for each chain (using the iterations that were kept
following the burn-in process) using the effectiveSize function in the coda [48]
package in R [49]. Convergence diagnostics for the chains are shown in S3 File.
The marginal posterior distributions in this study are plotted in S4 File using all
samples from the chains (after burn-in), without thinning. When using the joint
posterior distribution to make predictions, we used 104 parameter sets corresponding
to uniformly spaced iterations in each of the chains.
Results were visualised using MATLAB R2015b [50].
Model predictions
First, to determine whether the fitted model captured the timing and strength of each
immune component during a primary infection, we used parameter sets from the joint
posterior distribution to simulate the viral load during a single infection, using a
modified model where either
• adaptive immunity is suppressed;
• innate and adaptive immunity is suppressed;
• cellular adaptive immunity is suppressed; or
• humoral adaptive immunity is suppressed.
95% prediction intervals were constructed using these simulations.
Second, to determine whether the fitted model captured cross-protection between
strains, we used parameter sets from the joint posterior distribution to simulate
different inter-exposure intervals.
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Third, to determine whether the fitted model captured the contribution of each
immune component to cross-protection between strains, we used parameter sets from
the joint posterior distribution to simulate the viral load during sequential infection,
using a modified model where either
• cross-protection is only mediated by cellular adaptive immunity, and not target
cell depletion or innate immunity (model XC);
• cross-protection is mediated by innate immunity, but not target cell depletion or
cellular adaptive immunity (model XI); or
• cross-protection is mediated by target cell depletion and/or innate immunity, but
not cellular adaptive immunity (model XIT).
Details of models XC, XI and XIT are provided in S1 File.
Table 1 summarises the model modifications in this section.
Table 1. Summary of model modifications for predictions.
Model Target cells Interferon Antibodies T cells
Baseline shared shared separate partly shared
No adaptive immunity shared shared none none
No immunity shared none none none
No cellular adaptive immunity shared shared separate none
No humoral adaptive immunity shared shared none partly shared
XC separate separate separate partly shared
XI separate shared separate separate
XIT shared shared separate separate
‘Shared’ denotes that the compartment in the table header interacts with all virus strains. For example, if interferon are
‘shared’, all virus strains induce production of the same interferon, and interferon’s antiviral effects apply to all strains.
‘Separate’ denotes that the compartment interacts with one virus strain only. For example, if interferon are ‘separate’, each
virus strain induces the production of a separate pool of interferon, and the antiviral effects of each pool of interferon apply
only to that strain. T cells being ‘partly shared’ denotes that some T cell pools interact with one virus strain only, while
other T cell pools are stimulated by more than one strain and clear cells infected by any of those strains. ‘None’ denotes
that the compartment is removed from the model.
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Supporting information
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S1 Fig The full set of synthetic data. (a) The line shows the simulated ‘true’
viral load for a single infection, with the arrow showing the time of exposure. The
simulated observed viral loads for the thirteen single infection ferrets are shown as
crosses. The horizontal line indicates the observation threshold (10 RNA copy
no./100µL); observations below this threshold are plotted below this line. Values
below the observation threshold were treated as censored. (b–g) For sequential
infections with the labelled inter-exposure interval, the dashed and dotted lines show
the simulated ‘true’ viral load for a primary and challenge infection respectively; the
arrows show the times of the primary and challenge exposures. The simulated
observed viral load is shown as crosses. The sequential infection dataset consists of the
viral load for the six sequential infection ferrets and one single infection ferret; the
single infection dataset consists of the viral load for the thirteen single infection ferrets.
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S2 Fig Trajectories for model XI generated using 100 uniformly sampled
parameter sets from the MCMC chains after burn-in, for the model fitted
to sequential infection data. The darker trajectory incorrectly attributed the delay
observed in the baseline model to target cell depletion rather than innate immunity.
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(a) Model XI1
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(b) Model XI2
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(c) Model XI3
S3 Fig Sequential infection data did not enable accurate prediction of the
challenge viral load for a modified model where only one of the three
innate immune mechanisms mediates cross-protection. The challenge viral
load for the ‘true’ parameter values and a modified model where cross-protection is
mediated by only one innate immune mechanism (models XI1–XI3, red line) was
compared to the viral load for the baseline model (black line). At a one-day
inter-exposure interval, the delay in the baseline model occurred due to a combination
of innate immune mechanisms 2 and 3. Prediction intervals for the viral load for
models XI1–XI3 according to the model fitted to sequential infection data (blue areas)
did not accurately recover the viral load according to the ‘true’ parameters. Hence,
the fitted model did not attribute cross-immunity to the correct mechanisms of the
innate immune response.
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S4 Fig Compartmental diagram for two strains and three T cell pools.
Cells infected with influenza strain 1 stimulate naive CD8+ T cells in pools 1 and 3,
and are cleared by effector CD8+ T cells in these pools. Cells infected with influenza
strain 2 stimulate naive CD8+ T cells in pools 2 and 3, and are cleared by effector
CD8+ T cells in these pools.
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S1 Text. More details on the model fitting procedure.
S2 Text. Notes on biologically plausible ranges for the parameters pV ratio,
α and γ, as provided in S1 Table.
S1 File. Two-strain model equations for the baseline and modified models,
and compartmental diagrams for the modified models. In the baseline model,
naive CD8+ T cell pools 1 and 3 are stimulated by cells infected with strain 1, and
naive CD8+ T cell pools 2 and 3 are stimulated by cells infected with strain 2. The
clearance of infected cells by effector CD8+ T cells is similarly strain-specific.
S2 File. Results for an additional set of parameters where the degree of
cross-reactivity in the cellular adaptive immune response is high.
S3 File. Convergence diagnostics for the MCMC chains.
S4 File. Marginal posterior distributions for the model parameters.
S1 Table. Viral replication parameter values and prior bounds. Note that
the values and prior bounds are given in logarithmic space. For example, the value of
log10R0 was log10 4.9 and the prior bounds were [0, 3]. Hence, the value of R0 was 4.9
and the prior bounds of R0 were [1, 1000]. β and pV inf were not directly fitted, but
their values as recovered from Eqs. 7 and 9 could not exceed the bounds given.
Because total virions include infectious virions, the total virion decay rate should be
slower than the infectious virion decay rate. Hence, the difference between the
infectious and total virion decay rates δV inf − δV tot, rather than the infectious virion
decay rate δV inf , was fitted to ensure that the former quantity was positive. Notes on
biologically plausible ranges for the parameters ptot, α and γ are given in S2 Text.
S2 Table. Innate immune response parameter values and prior bounds.
S3 Table. Values and prior bounds for the cross-reactivity parameters in
the cellular adaptive immune response. The number of infected cells for
half-maximal stimulation of naive/memory CD8+ T cells kCjq and the (scaled)
clearance rate of infected cells by effector CD8+ T cells κE11.
S4 Table. Adaptive immune response and observation model parameter
values and prior bounds.
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